🧵 Abro hilo sobre 💉#DéficitDeHierro en adultos: ¿subestimamos su impacto en consulta? Datos, diagnóstico y tratamiento práctico para #HemaTwitter#MedEd#MIR.
Afecta a ≈2.000 millones 🌍; EE. UU. 14% de adultos déficit absoluto y 1,2 mil millones con anemia ferropénica.
los héroes de los perritos en las inundaciones de veracruz solo quiero decirles:
que sus días sean largos llenos de salud, muchas alegrías que cuando partan de este mundo sea con paz, que siempre tengan un pan para saciar su hambre y un vaso para apagar su sed. 🤍
@talapariente ¿Si sabes lo que sucede en ese mercado?
Si de verdad se consideran un partido “Verde” no deberia haber pauta para la negociación con los crimenes que ahi ocurren.
📊 How many patients with lymphoma or myeloma in the US actually benefit from bispecific antibodies?
In our @BloodAdvances letter, we estimate eligibility and response under current FDA labels—and why real-world benefit may be limited.
@THilalMD
https://t.co/RqjOpwIjzh
📢 Body composition in adult ALL
📊 In our study published at @ESPENorg, CT-assessed muscle mass & adiposity (visceral & subcutaneous) were linked to worse survival & more infections.
https://t.co/OQViWUy960
@RobertaDemiche3@FernandoGLMD@analymorac@JessicaZaS
Estudio que examina resultados a largo plazo de adultos hispanos no cirróticos diagnosticados con TVP en un centro en la Ciudad de México. Participacion del @incmnszmx . Fernando Gil -López y cols.
1/ 📢 Let’s dive into a crucial topic in #Hematology: How do adult regimens compare with pediatric-inspired regimens (PIRs) for Philadelphia-negative ALL? Our study from Mexico offers some insights #ALL@RobertaDemiche3@faustor@rajuan_27@analymorac
https://t.co/b8ydOWFbg5
1/ Rituximab in ALL: What we know
For Ph-neg B-ALL, rituximab has shown clear benefits:
🩺 Improved EFS (in trials like GRAALL-2005)
🩺 Enhanced outcomes, esp with ≥8 doses
But for Ph-pos B-ALL evidence is lacking, as most trials exclude these patients
CONGRESS | #ASH24 | POSTER
Fausto A Rios-Olais @faustor@incmnszmx shares findings from a study examining the relationship between metabolic complications and asparaginase-containing pediatric-inspired regimens in adult patients with ALL (N = 92).
Liver steatosis was associated with developing type 2 diabetes mellitus, which occurred in nearly 1 in 5 patients. Non-invasive liver steatosis assessment may identify patients who could benefit from early interventions to prevent metabolic complications.
Follow our live feed for more updates: https://t.co/fDCz3La5Dx
@RobertaDemiche3 #ALL #ALLsm #MedTwitter #MedicalCongress
The Mexican contingent at #ASH24
Fellows from INCMNSZ (Mexico city) HU UANL (Monterrey)… and two young-looking albeit wise junior faculty 😉@RobertaDemiche3
So glad to see the results of PI regimens implementation in our country by @RobertaDemiche3. Important data that encourages ALL research in LATAM @SocietyofHemOnc.
Calling all fellows & early-to mid-career #hematology faculty working in Latin American countries! Apply for the ASH Clinical Research Training Institute in Lain America! CRTI-LA includes didactic sessions, breakout groups & mentoring opportunities. Apply: https://t.co/u1ZV4GiuUs
🇲🇽Very pleased with this team effort to talk about sexuality in men with SLE. Let's make this information visible🎊🎉
#lupus#sexualfuction#male
👇👇👇
https://t.co/LAc5gbOcVC